[pending] TIMOLOL MALEATE (TIMOLOL MALEATE)
Pending LLM rewrite. Source: FDA_DRUG D-0403-2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
The recalled product
- Product
- TIMOLOL MALEATE (TIMOLOL MALEATE)
- Brand
- TIMOLOL MALEATE
- Manufacturer
- FDC Limited
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 083I098
- Exp. Date 08/31/2025
UPCs (2)
- 0364980513050
- 0364980514057
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TIMOLOL MALEATE
- ModerateTimolol Maleate eye drops recalled for defective dropper cap
FDA (Drugs) · 2025-02-12
- HighOphthalmic Eye Drops Recalled for Defective Container Cap Spike
FDA (Drugs) · 2024-12-18
- HighTimolol Maleate Eye Drops Recalled Due to Defective Container
FDA (Drugs) · 2024-11-13
- ModerateFDA recalls Timolol Maleate eye drops due to defective bottle cap
FDA (Drugs) · 2024-08-28
- HighOphthalmic solution recalled for defective container with lodged spike
FDA (Drugs) · 2024-08-21
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27